RTW INVESTMENTS, LP - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$73,505,075
-34.5%
7,136,415
+4.8%
1.55%
-27.4%
Q2 2023$112,239,364
+113.4%
6,810,641
+18.6%
2.14%
+95.2%
Q1 2023$52,596,161
+27.9%
5,741,9390.0%1.10%
+30.5%
Q4 2022$41,112,283
+42.9%
5,741,9390.0%0.84%
+26.5%
Q3 2022$28,767,000
+105.3%
5,741,9390.0%0.66%
+83.1%
Q2 2022$14,010,000
-64.3%
5,741,9390.0%0.36%
-55.4%
Q1 2022$39,217,000
-15.5%
5,741,9390.0%0.81%
+19.9%
Q4 2021$46,395,000
-17.6%
5,741,9390.0%0.68%
-20.3%
Q3 2021$56,271,000
+45.6%
5,741,9390.0%0.85%
+45.6%
Q2 2021$38,643,000
-25.6%
5,741,9390.0%0.58%
-28.0%
Q1 2021$51,907,000
+44.2%
5,741,939
+6.6%
0.81%
+34.1%
Q4 2020$35,989,000
+33.1%
5,387,513
+0.4%
0.60%
-7.2%
Q3 2020$27,048,000
-36.9%
5,366,705
+1.1%
0.65%
-46.0%
Q2 2020$42,877,000
+18.3%
5,306,570
+14.9%
1.21%
-22.7%
Q1 2020$36,253,000
+41.2%
4,616,570
+35.7%
1.56%
+61.1%
Q4 2019$25,681,0003,401,4340.97%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 985,210$10,345,0006.10%
Broadfin Capital, LLC 3,568,122$37,465,0005.54%
JW Asset Management, LLC 444,439$4,667,0003.42%
ARMISTICE CAPITAL, LLC 1,688,000$17,724,0002.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$38,383,0001.73%
FALCON POINT CAPITAL, LLC 661,490$6,284,0000.91%
KNOTT DAVID M 158,555$1,665,0000.71%
Perceptive Advisors 3,098,010$32,530,0000.62%
Sio Capital Management, LLC 91,413$960,0000.50%
HEARTLAND ADVISORS INC 700,000$7,350,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders